SMR Stock Slides As Citi Slashes Target After Q2 Shock

NuScale Power Corporation stocks have been trading down by -6.42 percent amid heightened concern over small modular reactor project delays.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading SMR

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

NuScale Power’s Q2 EPS of -$0.13 matched expectations, but revenue plunged to just $75,000 from $8M a year earlier, spotlighting how early SMR’s commercial story still is.
Citi cut its NuScale Power price target to $6.50 from $7.50 and reiterated a Sell rating, citing tiny revenue, heavy spending, and few near-term sales drivers.
Earlier in 2026, Citi had briefly nudged its NuScale Power target up to $7.50 from $7, but kept a Sell call, signaling long-standing concerns about SMR’s fundamentals.

Quick Financial Overview

SMR has been grinding higher on the chart even as NuScale Power’s fundamentals flash red. Over the past few weeks, SMR climbed from the mid‑$7s to the high‑$9s, with recent daily closes clustering between $9.00 and $9.80. That is a steady uptrend of roughly 25% from mid‑July to early August, not a parabolic spike. For active traders, that matters. It suggests persistent dip‑buying rather than a one‑day squeeze.

Intraday action in SMR shows tight trading ranges, with most 5‑minute candles on the latest day stuck between about $9.15 and $9.30 after an early fade from a $9.87 high. That’s classic consolidation near the top of a short‑term range. Meanwhile, NuScale Power’s Q2 numbers tell a different story: revenue of just $75,000, down from $8M a year earlier, and a net loss of about $47.5M.

More Breaking News

Margins are deeply negative, and the company posted an operating cash outflow of roughly $58M for the quarter. On the flip side, NuScale Power sits on around $776M of cash and no debt, giving SMR a long runway but no proof of commercial traction yet. Traders are betting on the story, not the income statement.

Why Traders Are Watching SMR After Citi’s Cut

NuScale Power and its SMR ticker sit at the crossroads of hype and hard reality. On one hand, management is touting strategic progress, U.S. Nuclear Regulatory Commission design certification, and a developed supply chain for its small modular reactor technology. On the other, SMR just printed Q2 revenue that collapsed to $75,000 from $8M. For a company with more than $2.0B in assets and over $766M in cash, that revenue line is almost a rounding error.

Citi’s latest move drove the point home. After earnings, the firm cut its NuScale Power price target to $6.50 from $7.50 and kept a Sell rating, calling out “insignificant revenue,” higher‑than‑expected spending, and limited near‑term sales drivers. That is a clear message to traders who only look at the SMR chart and ignore the filings. The bank had already been cautious. Back on 2026/07/22, Citi nudged its target up from $7 to $7.50 in a sector preview, but even then it stuck with a Sell on NuScale Power.

What changed is that the weak Q2 numbers gave Citi fresh ammo. SMR’s price has drifted well above those targets, recently trading around the high‑$9s. That disconnect between wall‑street modeling and market price is where short‑term traders hunt. If SMR keeps holding above $9 on heavy volume, momentum players will see a possible squeeze set‑up against a crowded bearish thesis. If the chart breaks down through recent support near $8.50–$9.00, you have a textbook pattern of a story stock finally catching up to its fundamentals.

Conclusion

NuScale Power is the kind of name that tempts active traders because the story is huge while the numbers are tiny. SMR offers exposure to small modular reactors, a concept many see as part of the long‑term energy mix. Yet current financials are brutal: Q2 revenue of $75,000, operating losses near $64M, and extremely negative profit margins. Citi’s Sell rating and $6.50 target underline that wall‑street remains skeptical that NuScale Power will turn its pipeline into meaningful revenue any time soon.

At the same time, SMR’s balance sheet is strong, with roughly $776M in cash and no debt, plus a current ratio near 38. That gives NuScale Power time to execute, which is why some traders feel comfortable riding the volatility on the long side despite Citi’s downgrade. The key is treating SMR as a trade, not a hope‑and‑forget position.

As Tim Sykes likes to remind his students, “The market doesn’t care about your opinion, only about price action and risk management.” In the same spirit, traders need a process for reviewing their actions and outcomes. As Tim Bohen, lead trainer with StocksToTrade says, “The best way to learn is by tracking trades, wins, losses, and lessons learned. Every trade has something to teach.”. For SMR, that means respecting both the bearish analyst view and the bullish chart. Study the Q2 earnings, track how NuScale Power trades around key levels, and be ready to cut losses fast if the story stops matching the price. This coverage is for educational and research purposes only, and every trader must make independent decisions based on their own plans and risk tolerance.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!